Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (Mayo) vs weekly high-dose 24 h 5-FU infusion/FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC). - Grothey,A.; Deschler,B.; Kroening,H. (Proc Am Soc Clin Oncol, 2002)